Compare Crispr Therapeutics AG (CRSP) vs Honeywell International Inc (HON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Honeywell International Inc — how do they compare? Crispr Therapeutics AG trades at $53.88 (market cap $5.17B), while Honeywell International Inc trades at $230.35 (market cap $76.99B). The key difference: Honeywell International Inc is far larger — about 14.9× Crispr Therapeutics AG's market cap, and Honeywell International Inc pays a 1.15% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | HON | |
|---|---|---|
Market Cap | $5.17B | $76.99B |
Sector | Health | Industrials |
52-Week High | $76.78 | $248.79 |
52-Week Low | $44.34 | $188.14 |
Enterprise Value | $3.59B | $101.79B |
Dividend Yield | — | 1.15% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →
